Co-Chairs

• Christopher P. Austin, M.D.
  Director
  National Center for Advancing Translational Sciences (NCATS)
  
  
• Story C. Landis, Ph.D.
  Director
  National Institute of Neurological Disorders and Stroke (NINDS)
  
  

Working Group Coordinators

• Kathy L. Kopnisky, Ph.D.
  Office of Biotechnology Activities
  Office of Science Policy
  Office of the Director
  National Institutes of Health (NIH)
  
  
• Vicki Seyfert-Margolis, Ph.D.
  Advisor to the Chief Scientist
  Food and Drug Administration (FDA)
  
  
• Danilo Tagle, Ph.D.
  Associate Director for Special Initiatives
  National Center for Advancing Translational Sciences (NCATS)
  
  

Members

• Guillermo Arreaza-Rubin
  Program Director
  Clinical Immunology of Diabetes
  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  
  
• John Timothy Baldwin, Ph.D.
  Deputy Chief
  Advanced Technologies and Surgery Branch
  Division of Cardiovascular Diseases,
  National Heart, Lung, and Blood Institute (NHLBI)
  
  
• David Balshaw, Ph.D.
  Program Director
  Center for Risk and Integrated Sciences
  Division of Extramural Research and Training
  National Institute of Environmental Health Sciences (NIEHS)
  
  
• Dana Bryant, MPH
  Program Analyst
  National Center for Advancing Translational Sciences (NCATS)
  
  
• Greg Campbell, Ph.D.
  Director
  Division of Biostatistics, Center for Devices and Radiological Health
  Food and Drug Administration (FDA)
  
  
• Christine Colvis, Ph.D.
  Program Director
  National Center for Advancing Translational Sciences (NCATS)
  
  
• Robin Conwit, M.D.
  Medical Officer
  Office of Clinical Research
  National Institute of Neurological Diseases and Stroke (NINDS)
  
  
• Bonnie B. Dunn, Ph.D.
  Scientific Review Officer
  National Center for Advancing Translational Sciences (NCATS)
  
  
• Suzanne Fitzpatrick, Ph.D.
  Senior Science Policy Analyst
  Office of the Commissioner
  Food and Drug Administration (FDA)
  
  
• Thomas Flammang, Ph.D.
  Associate Director
  National Center for Toxicological Research
  Food and Drug Administration (FDA)
  
  
• Ronald N. Germain, M.D., Ph.D.
  NIH Distinguished Investigator
  Chief, Laboratory of Systems Biology
  Chief, Lymphocyte Biology Section
  Associate Director, Trans-NIH Center for Human Immunology (CHI)
  National Institute of Allergy and Infectious Diseases (NIAID)
  
  
• David Jacobson-Kram, Ph.D.
  Associate Director
  Office of New Drugs
  Center for Drug Evaluation and Research
  Food and Drug Administration (FDA)
  
  
• Scott Janis, Ph.D.
  Program Director
  Office of Clinical Research
  National Institute of Neurological Diseases and Stroke (NINDS)
  
  
• Lyric Jorgenson, Ph.D.
  Office of Science Policy Analysis
  Office of the Director
  National Institutes of Health (NIH)
  
  
• Holli Hamilton, M.D., M.P.H.
  Senior Medical Officer
  Division of Extramural Research
  National Institute of Dental and Craniofacial Research (NIDCR)
  
  
• Lori Henderson, Ph.D.
  Program Director
  Division of Discovery Science and Technology
  National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  
  
• Rosemarie Hunziker, Ph.D.
  Program Director
  Division of Discovery Science and Technology
  National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  
  
• Jennie Larkin, Ph.D.
  Program Director
  National Heart, Lung, and Blood Institute (NHLBI)
  
  
• Albert Lee, Ph.D.
  Program Director, Advanced Technologies and Surgery Branch
  Division of Cardiovascular Diseases
  National Heart, Lung, and Blood Institute (NHLBI)
  
  
• Sara Lin, Ph.D.
  Program Director
  Lung Biology and Disease Branch
  National Heart, Lung, and Blood Institute (NHLBI)
  
  
• Nadya Lumelsky, Ph.D.
  Director
  Tissue Engineering and Dental and Craniofacial Regenerative Medicine Research Program
  Integrative Biology and Infectious Disease Branch
  National Institute of Dental and Craniofacial Research (NIDCR)
  
  
• Martha S. Lundberg, Ph.D.
  Program Director, Tissue Engineering
  Division of Cardiovascular Sciences
  National Heart, Lung, and Blood Institute (NHLBI)
  
  
• Subhas Malghan, Ph.D.
  Deputy Director
  Office of Science Engineering Laboratories
  Center for Devices and Radiological Health
  Food and Drug Administration (FDA)
  
  
• Brenton McCright, Ph.D.
  Research Biologist
  Center for Biologics Evaluation Research
  Food and Drug Administration (FDA)
  
  
• Matthew McMahon, Ph.D.
  Senior Advisor for Translational Research
  Office of the Director
  National Eye Institute (NEI)
  
  
• Richard T. Okita, Ph.D.
  Program Director
  Division of Pharmacology, Physiology, and Biological Chemistry
  National Institute of General Medical Sciences (NIGMS)
  
  
• Robert T. O'Neill, Ph.D.
  Director
  Office of Biostatistics
  Center for Drug Evaluation and Research
  Food and Drug Administration (FDA)
  
  
• Thomas Palker, Ph.D.
  Program Officer
  Division of Allergy, Immunology, and Transplantation
  National Institute of Allergy and Infectious Diseases (NIAID)
  
  
• Carlos Pena, Ph.D.
  Senior Science Policy Advisor
  Office of the Commissioner
  Food and Drug Administration (FDA)
  
  
• Mary Ellen Perry, Ph.D.
  Program Leader
  Office of Strategic Coordination
  Division of Program Coordination, Planning, and Strategic Initiatives
  Office of the Director
  National Institutes of Health (NIH)
  
  
• J. Thomas Peterson, Ph.D.
  Chief
  Bioengineering Sciences and Technologies
  Center for Scientific Review (CSR)
  
  
• Estelle Russek-Cohen, Ph.D.
  Supervisory Math Statistician
  Center for Biologics Evaluation Research
  Food and Drug Administration (FDA)
  
  
• Jonathan Sackner-Bernstein, M.D.
  Associate Director
  Center for Devices and Radiological Health
  Food and Drug Administration (FDA)
  
  
• Grace Shen, Ph.D.
  Group Leader
  Corneal Diseases and Ocular Immunology, Inflammation, & Infection
  National Eye Institute (NEI)
  
  
• Douglas M. Sheeley, Sc.D.
  Deputy Director
  Division of Biomedical Technology
  National Center for Research Resources (NCRR)
  
  
• William Slikker, Jr., Ph.D.
  Director
  National Center for Toxicological Research
  Food and Drug Administration (FDA)
  
  
• Robert Star, M.D.
  Director
  Division of Kidney, Urologic, and Hematologic Diseases
  National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK)
  
  
• Margaret Sutherland, Ph.D.
  Program Director
  Neurodegeneration Cluster
  National Institute of Neurological Diseases and Stroke (NINDS)
  
  
• Robert Temple, M.D.
  Deputy Director of Clinical Science,
  Center for Drug Evaluation and Research
  Food and Drug Administration (FDA)
  
  
• James V. Tricoli, Ph.D.
  Program Director
  Diagnostic Biomarkers and Technology Branch
  Cancer Diagnosis Program
  Division of Cancer Treatment and Diagnosis
  National Cancer Institute (NCI)
  
  
• Hung Tseng, Ph.D.
  Health Scientist Administrator
  Division of Skin and Rheumatic Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  
  
• Lois A. Tully, Ph.D.
  Program Director
  Division of Extramural Activities
  National Institute of Nursing Research (NINR)
  
  
• Fei Wang, Ph.D.
  Health Scientist Administrator
  Division of Musculoskeletal Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  
  
• Celia Witten, M.D., Ph.D.
  Director
  Office of Cellular Tissue & Gene Therapies
  Center for Biologics Evaluation Research
  Food and Drug Administration (FDA)
  
  
• Jerome Wujek, Ph.D.
  Research Resources Officer
  National Eye Institute (NEI)
  
  
• Anne Zajicek, M.D., Pharm.D.
  Acting Chief
  Obstetric & Pediatric Pharmacology Branch
  National Institute of Child Health and Human Development (NICHD)
  
  
• Bram Zuckerman, M.D.
  Director
  Division of Cardiovascular Devices
  Center for Devices and Radiological Health
  Food and Drug Administration (FDA)
  
  
• Steve Zullo, Ph.D.
  Program Director
  Division of Discovery Science and Technology
  National Institute of Biomedical Imaging and Bioengineering (NIBIB)